The coronavirus has had a significant impact in the Middle East & Africa. Iran was one of the pandemic's first victims, with fatal cases reported as early as March 2020. Middle East & Africa countries, saw three waves of the pandemic, with a few outliers. However, due to insufficient diagnosis and reporting systems in some countries, a comparable cross-country examination of infection intensity is challenging. The relative frequency of testing can be used as an indirect indicator of the diagnostic system's performance. The United Arab Emirates (UAE) and Bahrain have been regional leaders in terms of testing, outperforming some advanced economies. Obstructive sleep apnea and other sleep disorders have comorbidities with severe acute respiratory syndrome coronavirus 2 infection, which are linked to poor outcomes. However, the prevalence of obstructive sleep apnea and its association with outcomes in COVID-19 patients is little understood, and the significance of other sleep disorders is uncertain. There appears to be a clear link between being overweight or obese and the probability of hospitalization and necessitating treatment in intensive care units for people with coronavirus illness 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ICUs). According to new research, obese people under the age of 60 are more likely to be hospitalized. Obesity prevalence rates are among the highest in the world in the Middle East. Given the exponential rise in the incidence of obesity, knowing how obesity increases the risk of severe COVID-19 infection is crucial for developing effective interventional and preventative treatments for this novel coronavirus.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa sleep apnea diagnostics market. The Middle East & Africa sleep apnea diagnostics market is expected to grow at a good CAGR during the forecast period.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 20.88 Million |
| Market Size by 2028 | US$ 27.01 Million |
| CAGR (2021 - 2028) | 3.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Sleep Apnea Diagnostics Market is valued at US$ 20.88 Million in 2021, it is projected to reach US$ 27.01 Million by 2028.
As per our report Middle East and Africa Sleep Apnea Diagnostics Market, the market size is valued at US$ 20.88 Million in 2021, projecting it to reach US$ 27.01 Million by 2028. This translates to a CAGR of approximately 3.7% during the forecast period.
The Middle East and Africa Sleep Apnea Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Sleep Apnea Diagnostics Market report:
The Middle East and Africa Sleep Apnea Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Sleep Apnea Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Sleep Apnea Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Sleep Apnea Diagnostics Market
